Engineering and Expression Strategies for Optimization of L-Asparaginase Development and Production
International Journal of Molecular Sciences · 16.10.2023 · 24 (20) · 15220
DOI: 10.3390/ijms242015220 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.10.2023. Verfasst von Anastasiya N Shishparenok und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Biotechnology, Institute of Biomedical Chemistry, Pogodinskaya St. 10/8, 119121 Moscow, Russia. Hauptthemen laut MEDLINE: Leukemia, Antineoplastic Agents. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 296 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education and Science of the Russian Federation.
Abstract (Originalsprache)
Genetic engineering for heterologous expression has advanced in recent years. Model systems such as Escherichia coli, Bacillus subtilis and Pichia pastoris are often used as host microorganisms for the enzymatic production of L-asparaginase, an enzyme widely used in the clinic for the treatment of leukemia and in bakeries for the reduction of acrylamide. Newly developed recombinant L-asparaginase (L-ASNase) may have a low affinity for asparagine, reduced catalytic activity, low stability, and increased glutaminase activity or immunogenicity. Some successful commercial preparations of L-ASNase are now available. Therefore, obtaining novel L-ASNases with improved properties suitable for food or clinical applications remains a challenge. The combination of rational design and/or directed evolution and heterologous expression has been used to create enzymes with desired characteristics. Computer design, combined with other methods, could make it possible to generate mutant libraries of novel L-ASNases without costly and time-consuming efforts. In this review, we summarize the strategies and approaches for obtaining and developing L-ASNase with improved properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Medical Biotechnology, Institute of Biomedical Chemistry, Pogodinskaya St. 10/8, 119121 Moscow, Russia.
- Department of Biochemistry, Peoples' Friendship University of Russia named after Patrice Lumumba (RUDN University), Miklukho-Maklaya St. 6, 117198 Moscow, Russia.
ORCID-Profile: Dmitry D Zhdanov
Förderung
- Ministry of Education and Science of the Russian Federation
Zitieren
APA
Shishparenok, A. N., Gladilina, Y. A., & Zhdanov, D. D. (2023). Engineering and Expression Strategies for Optimization of L-Asparaginase Development and Production. International Journal of Molecular Sciences, 24(20), 15220. https://doi.org/10.3390/ijms242015220
Vancouver
Shishparenok AN, Gladilina YA, Zhdanov DD. Engineering and Expression Strategies for Optimization of L-Asparaginase Development and Production. International Journal of Molecular Sciences. 2023;24(20):15220. doi:10.3390/ijms242015220
BibTeX
@article{Shishparenok2023,
author = {Shishparenok, Anastasiya N and Gladilina, Yulia A and Zhdanov, Dmitry D},
title = {Engineering and Expression Strategies for Optimization of L-Asparaginase Development and Production},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {20},
pages = {15220},
doi = {10.3390/ijms242015220}
}
EUVIMED